# Flerie

Flerie is an Asset Manager based in Stockholm, Sweden.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Stockholm, Sweden
- **Region:** Europe
- **Address:** Birger Jarlsgatan 13, 111 45 Stockholm, Sweden
- **Founded:** 2011
- **Assets under management:** Undisclosed
- **Website:** flerie.com
- **LinkedIn:** https://linkedin.com/company/flerie

## Regulatory record

- **Reports private funds:** No

## About

Flerie is an active long-term life science investor that builds companies with pioneering pharmaceutical and biotech projects or adjacent capabilities. The firm uses its network, expertise and resources to achieve long-term success for its portfolio companies. Flerie focuses on making a positive impact on health and well-being.

## Sectors

- Biotechnology
- Pharmaceuticals
- Digital Health

## Offices

- London, United Kingdom
- Matfors, Sweden

## People

- Thomas Eldered — Founder and Executive Chairman
- Ted Fjällman — CEO of Flerie AB and Partner at Flerie Invest

## Questions

### Who runs investment decisions at Flerie?

Investment operations are led by CEO and Partner Ted Fjällman, who reports to Founder and Executive Chairman Thomas Eldered. Eldered co-founded Recipharm, the CDMO sold to EQT in 2021, and his pharmaceutical operating experience shapes the firm's investment posture. Flerie emphasizes active, long-term stewardship rather than passive capital allocation.

### Does Flerie maintain any operating assets beyond its investment portfolio?

Yes. Flerie holds NorthX Biologics, a biomanufacturing facility located in Matfors, Sweden. This industrial asset complements the firm's financial portfolio and provides direct operational exposure to biologics production — a differentiator from most life-science investment firms that hold only financial stakes.

### How does Flerie source and support its portfolio companies?

The firm leverages its leadership's pharmaceutical operating background and an extensive network of Key Opinion Leaders, including clinicians featured in its Flerie Insights podcast series. Industry association memberships — the European Healthcare Investor Association, British Venture Capital Association, and SwedenBIO — provide additional sourcing channels. Flerie differentiates itself by actively advancing portfolio companies' clinical pipelines through hands-on involvement rather than purely financial engineering.

## Related profiles

- [Fledge](https://altss.com/profile/fledge)
- [Fletch Equity](https://altss.com/profile/fletch-equity)

---

Last updated: 2026-07-10T23:34:00.000Z

Canonical page: https://altss.com/profile/flerie-invest

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology